425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are moving forward with a proposed business combination, as detailed in a recent SEC filing.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was reposted by Avik Roy, a Board Member of Strive, Inc., on December 4, 2025.
• The filing includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with the transaction.
• Strive has filed a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, to register Class A common stock for the transaction.
• Stockholders of Semler Scientific will receive a definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• Both companies and their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.

Sentiment

Score: 6

Explanation: The filing announces a significant strategic move (merger) which is generally positive for growth, but it is heavily weighted with extensive cautionary statements and a comprehensive list of risks, making the immediate sentiment cautiously optimistic rather than overwhelmingly positive. The procedural nature of the 425 filing also limits strong sentiment.

Positives

• The proposed transaction aims to achieve strategic and financial benefits for the combined company.
• The merger is expected to impact the combined company's future financial performance positively.
• Anticipated benefits include cost savings and strategic gains.

Negatives

• The filing highlights numerous risks and uncertainties that could prevent the realization of anticipated benefits or cause actual results to differ materially.
• Potential for integration difficulties, higher costs, and longer completion times than expected.
• Risk of dilution for Strive shareholders due to the issuance of additional Class A common stock.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including positive impacts on future financial performance, cost savings, and strategic gains. However, these are forward-looking statements subject to significant risks and uncertainties, including the successful integration of businesses and market conditions.

Management Comments

• Avik Roy, Board Member of Strive, Inc., reposted the communication on X.com on December 4, 2025.

Industry Context

The mention of "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets" suggests that the combined entity may be involved in or planning to adopt strategies related to digital asset management, aligning with a growing trend among some corporations to incorporate cryptocurrencies into their balance sheets or operations. This could position the combined company within the evolving digital asset economy, potentially attracting investors interested in this sector.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of new Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the merger.
• Business and employee relationships at both companies could change as a result of the announcement or completion of the transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will vote on the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.
• The companies will work towards satisfying the conditions to closing the merger.
• Integration of the combined businesses will commence upon successful closing.

Key Dates

Keywords

Merger, Acquisition, Business Combination, SEC Filing, Form 425, Strive Inc., Semler Scientific, Corporate Governance, Risk Factors, Bitcoin Treasury, Digital Assets, Shareholder Approval